ArticleSage open pediatrics
Enhancing the Appropriate Use of Vancomycin in Pediatric Patients: The Impact of Drug Utilization Evaluation and Infectious Disease Consultation.
Article in Sage open pediatrics. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This study evaluated the impact of a drug utilization evaluation (DUE) program on vancomycin prescribing appropriateness and examined clinical factors, including infectious disease (ID) consultation, associated with appropriate use in a pediatric setting. Methods: A historical-control study was conducted among hospitalized children under 18 years who received intravenous vancomycin from January 2020 to January 2022. Prescriptions before DUE implementation were retrospectively reviewed (non-DUE group). From February 2021, a voluntary DUE program was introduced (DUE group). Demographic and clinical data were collected. Results: Among 423 prescriptions (232 non-DUE; 191 DUE), appropriateness was significantly higher in the DUE group (87.9% vs 72.0%; Conclusion: Implementation of a DUE program improved vancomycin prescribing appropriateness, with ID consultation serving as an additional contributor to appropriate use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.